{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:05:08Z","timestamp":1792310708236,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":500,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/s10156-013-0641-6","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T04:33:58Z","timestamp":1373258038000},"page":"787-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Vaccine chronicle in Japan"],"prefix":"10.1016","volume":"19","author":[{"given":"Tetsuo","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-013-0641-6_bib0005","series-title":"Vaccines","first-page":"1","article-title":"A short history of vaccination","author":"Plotkin","year":"2007"},{"key":"10.1007\/s10156-013-0641-6_bib0010","unstructured":"Ogawa T. Igaku no rekishi. Chukoushinsho 39, Chuoukouronnsya (in Japanese); 1964."},{"key":"10.1007\/s10156-013-0641-6_bib0015","first-page":"61858","article-title":"Learning from the US immunization administration","volume":"66","author":"Kamiya","year":"2008","journal-title":"Nihon Rinsho"},{"key":"10.1007\/s10156-013-0641-6_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","article-title":"Adverse events associated with MMR vaccines in Japan","volume":"38","author":"Kimura","year":"1996","journal-title":"Acta Paediatr Jpn"},{"key":"10.1007\/s10156-013-0641-6_bib0025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(95)92311-X","article-title":"Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan","volume":"346","author":"Ueda","year":"1995","journal-title":"Lancet"},{"key":"10.1007\/s10156-013-0641-6_bib0030","first-page":"1520","article-title":"Global routine vaccination coverage, 2010","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0035","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1472-698X-9-S1-S2","article-title":"Global immunization: status, progress, challenges and future","volume":"9","author":"Philippe","year":"2009","journal-title":"BMC Int Health Hum Rights"},{"key":"10.1007\/s10156-013-0641-6_bib0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/CMR.14.4.872-908.2001","article-title":"Active immunization in the United States: developments over the past decade","volume":"14","author":"Dennehy","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1007\/s10156-013-0641-6_bib0045","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Minireview: Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1007\/s10156-013-0641-6_bib0050","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.vaccine.2012.04.026","article-title":"Current issues with the immunization program in Japan: can we fill the \u201cvaccine gap\u201d?","volume":"30","author":"Saitoh","year":"2012","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.healthpol.2012.05.012","article-title":"The vaccine gap between Japan and the UK","volume":"107","author":"Shimazawa","year":"2012","journal-title":"Health Policy"},{"key":"10.1007\/s10156-013-0641-6_bib0060","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.vaccine.2009.01.030","article-title":"Leadership in immunization: the relevance to Japan of the U.S.A. experience of the Centers for Disease Control and prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP)","volume":"27","author":"Kamiya","year":"2009","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.09.32","article-title":"Review of 8\u00a0years of experience with Infanrix hexa\u2122 (DTPa-HBV-IPV\/Hib hexavalent vaccine)","volume":"8","author":"Zepp","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1007\/s10156-013-0641-6_bib0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/clinids\/5.3.495","article-title":"Measles vaccine in Japan","volume":"5","author":"Hirayama","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1007\/s10156-013-0641-6_bib0075","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2009.02.076","article-title":"Development of the rubella vaccine and vaccination strategy in Japan","volume":"27","author":"Ueda","year":"2009","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10156-002-0206-6","article-title":"Current status of measles in Japan","volume":"9","author":"Nakayama","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-013-0641-6_bib0085","first-page":"1049","article-title":"Progress toward measles elimination: Japan, 1999\u20132008","volume":"57","year":"2008","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0090","first-page":"169","article-title":"Multistate measles outbreak associated with an international youth sporting event\u2014Pennsylvania, Michigan, and Texas, August\u2013September 2007","volume":"57","year":"2007","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0095","first-page":"203","article-title":"Outbreak of measles: San Diego, California, January\u2013February 2008","volume":"57","year":"2008","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0100","first-page":"12","article-title":"Outbreak of measles in Geneva, Switzerland, March\u2013April 2007","author":"Delaportel","year":"2007","journal-title":"Euro Surveill"},{"key":"10.1007\/s10156-013-0641-6_bib0105","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/jmv.21372","article-title":"Modified adult measles in outbreak in Japan, 2007\u201308","volume":"81","author":"Nagai","year":"2009","journal-title":"J Med Virol"},{"key":"10.1007\/s10156-013-0641-6_bib0110","first-page":"239","article-title":"Measles and rubella in Japan, as of March 2006","volume":"28","year":"2007","journal-title":"IASR"},{"key":"10.1007\/s10156-013-0641-6_bib0115","doi-asserted-by":"crossref","first-page":"e50660","DOI":"10.1371\/journal.pone.0050660","article-title":"Molecular evolution of hemagglutinin (h) gene in measles virus genotypes d3, d5, d9, and h1","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1007\/s10156-013-0641-6_bib0120","first-page":"1605","article-title":"Increased transmission and outbreaks of measles\u2014European region, 2011","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0125","first-page":"73","article-title":"Measles virus nomenclature update: 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1007\/s10156-013-0641-6_bib0130","first-page":"1237","article-title":"Progress in global measles control and mortality reduction, 2000\u20132006","volume":"56","year":"2007","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0135","first-page":"349","article-title":"Measles vaccines: WHO position paper","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1007\/s10156-013-0641-6_bib0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7883\/yoken.JJID.2003.81","article-title":"Rubella and congenital rubella syndrome in Japan: epidemiological problems","volume":"56","author":"Terada","year":"2003","journal-title":"Jpn J Infect Dis"},{"key":"10.1007\/s10156-013-0641-6_bib0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jmv.23199","article-title":"Phylogenetic analysis of rubella viruses in Vietnam during 2009\u20132010","volume":"84","author":"Tran","year":"2012","journal-title":"J Med Virol"},{"key":"10.1007\/s10156-013-0641-6_bib0150","first-page":"657","article-title":"Recommendations from Ad Hoc Meeting of the WHO measles and rubella laboratory network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance","volume":"57","year":"2008","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0155","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2012.04.058","article-title":"Research priorities for global measles and rubella control and eradication","volume":"30","author":"Goodson","year":"2012","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0160","first-page":"129","article-title":"Poliomyelitis in Japan during the period 1962\u201368 after the introduction of mass vaccination with Sabin vaccine","volume":"49","author":"Takatsu","year":"1973","journal-title":"Bull World Health Org"},{"key":"10.1007\/s10156-013-0641-6_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2222\/jsv.62.57","article-title":"Poliovirus vaccine","volume":"62","author":"Scimizu","year":"2012","journal-title":"Uirusu"},{"key":"10.1007\/s10156-013-0641-6_bib0170","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.vaccine.2011.12.050","article-title":"Ten years after polio eradication from the WPRO region: current status and future problems","volume":"30","author":"Miyamura","year":"2012","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0175","series-title":"Vaccines","first-page":"467","article-title":"Pertussis vaccines","author":"Edwards","year":"2008"},{"key":"10.1007\/s10156-013-0641-6_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1442-200X.1988.tb02512.x","article-title":"Pertussis vaccines in Japan","volume":"30","author":"Kimura","year":"1988","journal-title":"Acta Paediatr Jpn"},{"key":"10.1007\/s10156-013-0641-6_bib0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0140-6736(90)91530-N","article-title":"Development in pertussis immunization in Japan","volume":"336","author":"Kimura","year":"1990","journal-title":"Lancet"},{"key":"10.1007\/s10156-013-0641-6_bib0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet"},{"key":"10.1007\/s10156-013-0641-6_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2003.11.001","article-title":"Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan","volume":"32","author":"Kuno-Sakai","year":"2004","journal-title":"Biologicals"},{"key":"10.1007\/s10156-013-0641-6_bib0200","doi-asserted-by":"crossref","first-page":"e31985","DOI":"10.1371\/journal.pone.0031985","article-title":"Prevalence and genetic characterization of pertactin-deficient Bordetalla pertussis in Japan","volume":"7","author":"Otsuka","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1007\/s10156-013-0641-6_bib0205","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2169\/internalmedicine.50.4768","article-title":"Outbreak of pertussis in a university laboratory","volume":"50","author":"Miyashita","year":"2011","journal-title":"Intern Med"},{"key":"10.1007\/s10156-013-0641-6_bib0210","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1440-1843.2011.02024.x","article-title":"Evaluation of serological tests for diagnosis of Bordetella pertussis infection in adolescents and adults","volume":"16","author":"Miyashita","year":"2011","journal-title":"Respirology"},{"key":"10.1007\/s10156-013-0641-6_bib0215","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/JCM.44.5.1899-1902.2006","article-title":"Development and evaluation of a loop-mediated isothermal amplification method for rapid diagnosis of Bordetella pertussis infection","volume":"44","author":"Kamachi","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-013-0641-6_bib0220","first-page":"1","article-title":"Recommendations and reports. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children: Recommendation of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants.","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1007\/s10156-013-0641-6_bib0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00431-008-0744-8","article-title":"Neonatal pertussis presenting as acute bronchiolitis: direct detection of the Bordetella pertussis genome using loop-mediated isothermal amplification","volume":"168","author":"Nakamura","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1007\/s10156-013-0641-6_bib0235","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee of Immunization Practices (ACIP)","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0240","first-page":"1279","article-title":"FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1007\/s10156-013-0641-6_bib0245","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1016\/j.vaccine.2010.09.050","article-title":"Safe and effective booster immunization using DTaP in teenagers","volume":"28","author":"Okada","year":"2010","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0250","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1586\/erv.12.83","article-title":"Resurgence of pertussis calls for re-evaluation of pertussis animal models","volume":"11","author":"Ark","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1007\/s10156-013-0641-6_bib0255","unstructured":"Wood JM, Williams MS (1998) In: Nicholson KG, Webster RG, Hay AJ (eds) Textbook of influenza. Blackwell, Oxford, pp 317\u2013323"},{"key":"10.1007\/s10156-013-0641-6_bib0260","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cid\/cir336","article-title":"Influenza vaccination of schoolchildren and influenza outbreaks in a school","volume":"53","author":"Kawai","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-013-0641-6_bib0265","series-title":"Report C-010.","article-title":"(The Maebashin Research Group for the Study of Influenza Epidemics). Influenza epidemics in the non-vaccinated area.","author":"Yugami","year":"1987"},{"key":"10.1007\/s10156-013-0641-6_bib0270","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1016\/j.vaccine.2008.06.036","article-title":"Ecological fallacy and skepticism about influenza vaccine efficacy in Japan: the Maebashi study","volume":"26","author":"Hirota","year":"2008","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0275","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.vaccine.2008.06.042","article-title":"History of influenza vaccination programs in Japan","volume":"26","author":"Hirota","year":"2008","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1007\/s10156-013-0641-6_bib0285","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/erv.09.15","article-title":"Current status and progress of prepandemic and pandemic influenza vaccine development","volume":"8","author":"Leroux-Roels","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1007\/s10156-013-0641-6_bib0290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(97)11212-0","article-title":"Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus","volume":"351","author":"Claas","year":"1998","journal-title":"Lancet"},{"key":"10.1007\/s10156-013-0641-6_bib0295","first-page":"200","article-title":"The WHO pandemic influenza preparedness framework: a milestone in global governance for health","volume":"306","author":"Fidler","year":"2012","journal-title":"JAMA"},{"key":"10.1007\/s10156-013-0641-6_bib0300","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1016\/j.vaccine.2010.07.034","article-title":"Conference report: Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials. World Health Organization, Geneva, Switzerland, 17\u201318 February 2010","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0305","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.vaccine.2012.04.004","article-title":"Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions","volume":"30","author":"Nakayama","year":"2012","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0310","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1097\/00006454-199809001-00019","article-title":"Childhood bacterial meningitis in Japan","volume":"17","author":"Kamiya","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1007\/s10156-013-0641-6_bib0315","doi-asserted-by":"crossref","first-page":"931","DOI":"10.11150\/kansenshogakuzasshi1970.75.931","article-title":"The trend of childhood bacterial meningitis in Japan (1997.7\u20132000.6)","volume":"75","author":"Sunakawa","year":"2001","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1007\/s10156-013-0641-6_bib0320","first-page":"570","article-title":"A post-marketing clinical study of Haemophilus influenza type b [Hib] conjugate vaccine (ActHIBR): interim analysis of primary immunization","volume":"115","author":"Yoshioka","year":"2011","journal-title":"Nihon Shounikagakukai Zazzhi"},{"key":"10.1007\/s10156-013-0641-6_bib0325","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0950268809990239","article-title":"IPD Surveillance Study Group. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan","volume":"138","author":"Chiba","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1007\/s10156-013-0641-6_bib0330","first-page":"323","article-title":"Morphological changes penicillin-resistant Streptococcus pneumoniae and beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae after exposure to oral antibacterial agents.","volume":"65","author":"Chiba","year":"2012","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-013-0641-6_bib0335","first-page":"43","article-title":"Studies on the development of a live attenuated mumps virus vaccine","volume":"49","author":"Sasaki","year":"1976","journal-title":"Kitasato Arch Exp Med"},{"key":"10.1007\/s10156-013-0641-6_bib0340","first-page":"323","article-title":"Development of live attenuated mumps Torii vaccine strain: development and biological characteristics","volume":"9","author":"Hoshino","year":"1981","journal-title":"Clin Virol"},{"key":"10.1007\/s10156-013-0641-6_bib0345","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.vaccine.2005.11.068","article-title":"A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan","volume":"25","author":"Nagai","year":"2007","journal-title":"Vaccine"},{"key":"10.1007\/s10156-013-0641-6_bib0350","series-title":"Vaccines","first-page":"435","article-title":"Mumps vaccine","author":"Plotkin","year":"2008"},{"key":"10.1007\/s10156-013-0641-6_bib0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/INF.0b013e31818a8ca8","article-title":"Kinki Ambulatory Pediatrics Study Group. An office-based prospective study of deafness in mumps","volume":"28","author":"Hashimoto","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1007\/s10156-013-0641-6_bib0360","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1086\/522132","article-title":"Development of varicella vaccine","volume":"197","author":"Takahashi","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-013-0641-6_bib0365","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.60.6.805","article-title":"Application of a live varicella vaccine in children with acute leukemia or other malignant diseases","volume":"60","author":"Izawa","year":"1977","journal-title":"Pediatrics"},{"key":"10.1007\/s10156-013-0641-6_bib0370","first-page":"3","article-title":"Protection against varicella in family contacts by immediate inoculation with live varicella vaccine","volume":"59","author":"Asano","year":"1977","journal-title":"Pediatrics"},{"key":"10.1007\/s10156-013-0641-6_bib0375","series-title":"J Infect Chemother","article-title":"Varicella vaccination in Japan: necessity of implementing a routine vaccination program","author":"Ozaki","year":"2013"},{"key":"10.1007\/s10156-013-0641-6_bib0380","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1442-200X.1989.tb01375.x","article-title":"3-year study for the prevention of perinatal HBV infection under the standard method of the Ministry of Health and Welfare, Japan","volume":"31","author":"Kawabe","year":"1989","journal-title":"Acta Paediatr Jpn"},{"key":"10.1007\/s10156-013-0641-6_bib0385","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1872-034X.2009.00496.x","article-title":"Source of transmission in children with chronic hepatitis B infection after the implementation of a strategy for prevention in those at high risk","volume":"39","author":"Komatsu","year":"2009","journal-title":"Hepatol Res"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13700394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13700394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10156-013-0641-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:49:57Z","timestamp":1761158997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X13700394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1341321X13700394"],"URL":"https:\/\/doi.org\/10.1007\/s10156-013-0641-6","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine chronicle in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-013-0641-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}